HIV-1 Resistance Testing in Drug Development

7/25/00


Click here to start


Table of Contents

HIV-1 Resistance Testing in Drug Development

Introduction

Implications of HIV Drug Resistance (1)

Implications of HIV Drug Resistance (2)

What are some current limitations?

HIV Resistance Testing in Drug Development: Meeting Goals

Development of Meeting

HIV Resistance Collaborative Group Representation

Federal Register Announcement

Meeting Format

Objectives - Session 1: Resistance Technology

Objectives - Session 2: Clinical Validation

Objectives - Session 3: Practical Considerations

Objectives - Session 4: Potential Roles in Drug Development

Acknowledgments

Author: Heidi Jolson, M.D., M.P.H.